Ricki Carroll, MD, MBE

Financial relationships

  • Type of financial relationship:
    Other
    Ineligible company:
    Biomarin
    Topic:
    PI for achondroplasia trial
    Date added:
    09/20/2023
    Date updated:
    09/20/2024
  • Type of financial relationship:
    Other
    Ineligible company:
    Ascendis
    Topic:
    PI for achondroplasia trial
    Date added:
    09/20/2023
    Date updated:
    09/20/2024
  • Type of financial relationship:
    Other
    Ineligible company:
    Pfizer
    Topic:
    co-I for achondroplasia trial
    Date added:
    09/20/2023
    Date updated:
    09/20/2024
    Relationship end date:
    05/01/2023
  • Type of financial relationship:
    Other
    Ineligible company:
    QED
    Topic:
    co-I for achondroplasia trial
    Date added:
    09/20/2023
    Date updated:
    09/20/2024
    Relationship end date:
    07/31/2023
  • Type of financial relationship:
    Other
    Ineligible company:
    Medlife
    Topic:
    PI for RCDP natural history trial
    Date added:
    09/20/2023
    Date updated:
    09/20/2024
  • Type of financial relationship:
    Other
    Ineligible company:
    Actio
    Topic:
    Consultant, related to metatropic dysplasia
    Date added:
    09/20/2023
    Date updated:
    09/20/2024
  • Type of financial relationship:
    Other
    Ineligible company:
    Guidepoint
    Topic:
    Consultant, related to skeletal dysplasia interventions
    Date added:
    09/20/2023
    Date updated:
    09/20/2024
  • Type of financial relationship:
    Other
    Ineligible company:
    Ultragenyx
    Topic:
    PI for OI trial
    Date added:
    09/20/2023
    Date updated:
    09/20/2024
Return to NCHDE Ethics Education Series-Let's Get Ethical